Ganymede Bio and Kytopen to bring cloud-native structured data to gene-modified cell therapy
Credit: motorolka/Shutterstock
Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, and Kytopen, a leader in the development and commercialisation of non-viral transfection tools for genome engineering, today announced a partnership to bring the power of cloud native, structured data to Kytopen’s Flowfect platforms. Under this collaboration, the Kytopen transfection systems will integrate Ganymede’s Lab-as-Code platform for:
Register for FREE to unlock this article
Register with Scientific Computing World and gain unparalleled access to premium content and invaluable resources designed to keep you informed and ahead of the curve. By joining our community, you’ll enjoy FREE access to:
- Breaking news & updates: Keep up with the latest developments, market trends, and technological breakthroughs.
- Comprehensive articles & expert insights: Dive into detailed coverage of current trends, technologies, and innovations from leading experts in the field.
- Real-world case studies: Gain knowledge from real-world applications and success stories that highlight best practices and innovative solutions.
- Exclusive webinars & round tables: Be among the first to learn about and join upcoming webinars and round tables addressing key issues in scientific computing.
- In-depth reports & technical articles: Access insightful reports and whitepapers offering actionable information to support informed decision-making.
- Professional networking: Connect with a vibrant community of professionals, exchange ideas, and collaborate on projects.
Propel your career and projects forward with full articles and exclusive content. Sign up now to unlock Scientific Computing World’s premium access.
Sign up now - it’s fast, easy, and FREE!
Already registered? Log in here
You can see our full privacy policy here.
